Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
antiviral therapy
Biotech
Virios fails in fibromyalgia but claims efficacy in omicron era
While the prospect failed to improve pain more than placebo did, Virios is making the case that it was effective after the emergence of omicron.
Nick Paul Taylor
Sep 19, 2022 9:00am
Pfizer, in a rare COVID-19 setback, dumps Paxlovid's IV sibling
Feb 8, 2022 8:20am
Novartis splashes cash on COVID-19 antiviral, plans FDA filing
Jan 10, 2022 4:48am
Pfizer's COVID-19 antiviral is expected to work against omicron
Dec 14, 2021 10:30am
Pfizer's oral COVID antiviral cuts hospitalization, death by 89%
Nov 5, 2021 7:41am
Antios raises a further $75M to fuel pursuit of hepatitis B cure
Nov 3, 2021 9:15am